At Alderline Group, we are dedicated to helping individuals and communities live healthier, more fulfilling lives. Our vision is to be a catalyst for healthcare innovation, accelerating the development of products and services that set new standards for clinical efficacy, quality, cost-effectiveness, and accessibility of care.
We invest and partner with entrepreneurs who are driving breakthrough change often enabled by advances in technology, data, materials, or new business models and always underpinned by ethical and capable teams.
We are a differentiated investor and partner:
Central to our credo are core values that guide our actions, reflect our culture, and define our identity as a catalyst for positive change in the healthcare sector:
Former Chairman and CEO of Johnson & Johnson, where he served as one of only seven leaders to hold the dual Chairman and CEO role since the company's NYSE listing in 1944. Under his leadership, J&J's market capitalization grew from ~$180B to over $470B. West Point graduate; currently serves on the boards of Apple, IBM, JPMorgan Chase, and the Travis Manion Foundation.
Healthcare investor focused on biotechnology, pharmaceuticals, and digital health. Previously a leader in McKinsey & Company's life sciences practice, advising pharmaceutical companies and private investors. Now focused on identifying and supporting companies developing novel therapeutics at the intersection of technology and life sciences.
Former Global Chair of Investment Banking at J.P. Morgan Chase, where he advised healthcare companies across M&A, strategy, and financing for more than 30 years. Currently serves on the boards of BD (Becton Dickinson), Insulet Corporation, Eikon Therapeutics, and Nextech Invest. Co-founder of The Forest Group, a non-profit focused on children's mental health.